Trade Biogen Inc. - BIIB CFD

Trading Conditions

• Type: CFD
• Spread: 0.18
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 184.5
• Open: 182.48
• 1-Year Change: 27.26%
• Day's Range: 180.27 - 182.48

What is Biogen (BIIB)?

Biogen Inc. is a multinational biotechnology company specializing in the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases. Its portfolio includes treatments for multiple sclerosis, spinal muscular atrophy, and other central nervous system disorders. Biogen invests heavily in research and development to advance therapies in neuroscience, including gene therapy and biologics. The company collaborates with academic institutions and other organizations to foster innovation. Biogen operates globally, aiming to address unmet medical needs through scientific advancements and patient-focused solutions.

Biogen Stock Price Today: Live Overview

The price today is shaped by market activity with Biogen trading at $182.38. Today’s price range extends between $179.95 and $183.78, with a daily change of -1.4595%.

FAQ: Biogen (BIIB)

What is the current price of BIIB stock?

The current price stands at $182.38.

Does BIIB pay dividends?

Dividends are paid by the company via cash distributions (if applicable).

Does BIIB have a formal corporate presence or regional headquarters in the UAE?

Biogen has an official regional office in the UAE located in Dubai Internet City.

What is BIIB best known for?

Biogen is most famous for its biotechnology products focusing on neurological diseases.

What assets are typically shown together with BIIB?

Commonly shown alongside BIIB: BioLife Solutions Inc, Liquidia Technologies, Inc., Upexi Inc.